Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

buy

Neurocrine Bioscience buy Guggenheim

Neurocrine Bioscience

Start price

€144.40

/ 50%

Target price

31.07.27

Performance (%)

Price

Summary

This prediction is currently active. The BUY prediction by Guggenheim for Neurocrine Bioscience is nearly unchanged. This prediction currently runs until 31.07.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this prediction

Performance without dividends (%)

Name	1w
Neurocrine Bioscience
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by Guggenheim for this prediction

In the thread Neurocrine Bioscience diskutieren

Prediction Buy

Perf. (%)

Target price 192.874

Change

Ends at

Neurocrine Biosciences (NBIX) had its price target raised by Guggenheim from $200.00 to $222.00. They now have a "buy" rating on the stock.

Ratings data for NBIX provided by MarketBeat

0

Stopped prediction by Guggenheim for Neurocrine Bioscience

Neurocrine Bioscience

Start price

Target price

Perf. (%)

€157.15

21.07.27

50%

Neurocrine Bioscience

Start price

Target price

Perf. (%)

€123.15

06.05.27

50%

Neurocrine Bioscience

Start price

Target price

Perf. (%)

€108.15

06.05.26

50%

Neurocrine Bioscience

Start price

Target price

Perf. (%)

€120.00

10.02.26

50%

Neurocrine Bioscience

Start price

Target price

Perf. (%)

€140.30

02.08.25

50%

Neurocrine Bioscience

Start price

Target price

Perf. (%)

€131.25

02.05.25

50%